Solstein Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Solstein Capital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,130	Closed	-$462K	–	499
2021 Q1	$462K	Buy	+2,130	New	+$400K	0.63%	50

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Solstein Capital's GWPH Position: Q2 2021 in Review

Solstein Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2,130 shares — an estimated $462K sold.

Solstein Capital first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $462K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Solstein Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Solstein Capital sold 2,130 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $462K.
Solstein Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Solstein Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $462K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Solstein Capital's 13F filing for Q2 2021, filed 12 Aug 2021.